IUC24360-80

Abstract Code: IUC24360-80 Second-line therapies of Metastatic Renal Cell Carcinoma (mRCC) after 1st line immune-combinations (ICI-combos) (Meet-URO 33 study)   D. Bimbatti 1, C. Messina 2, L. Bonomi 3, S. Scagliarini 4, S. Chiellino 5, B.A. Maiorano 6, F.M. Deppieri...

IUC24358-87

Abstract Code: IUC24358-87 Prognostic assessment of the Meet-URO score compared with the IMDC score in Metastatic Renal Cell Carcinoma (mRCC) receiving 1st line systemic therapies (Meet-URO 33 study)   S.E. Rebuzzi 1, C. Messina 2, L. Bonomi 3, S. Scagliarini 4, S....

IUC22940-82

Abstract Code: IUC22940-82 A 7-Year Review of Robot-Assisted vs Laparoscopic Radical Nephrectomy at a UK District General Hospital (2018–2024) A. Hossain 1, S. Khan 1, A. Albnhawy 2 (1) Surrey and Sussex Healthcare NHS Trust – United Kingdom, (2) Redhill –...

IUC24415-81

Abstract Code: IUC24415-81 Clinical outcomes in stage I seminoma patients aged ≥ 45 years according to treatment modality F. Mascaro 1, A. Marmiroli 2, A. Nuzzo 2, M. Maruzzo 3, D. Bimbatti 3, S. Nazzani 2, M. Claps 2, G. Procopio 2, N. Nicolai 2, P. Giannatempo 2 (1)...

IUC24429-86

Abstract Code: IUC24429-86   Real-World Use of Bone-Modifying Agents (BMA) in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Z.I. Ozay 1, Y. Jo 1, M. Ostrowski 1, N. Sayegh 1, R. Graf 2, S. Roy 3, E. Antonarakis 4, R. McKay 5, N....
error: Content is protected !!